Dr. Zheng obtained her Ph.D. degree from Baylor College of Medicine in 1990. After a brief postdoctoral training at Baylor, she joined Merck & Co. where she began her research on Alzheimer’s disease, which continued after her return to Baylor in 1999. Dr. Zheng’s expertise is mouse genetics and she is a pioneer in utilizing sophisticated mouse models to probe the biology and pathophysiology of the amyloid precursor protein and presenilins. Dr. Zheng’s current research focuses on the investigation of the autophagy-lysosomal pathway and neuron-immune interaction in Alzheimer’s and related disorders.

Dr. Zheng has published over 100 papers. She is a recipient of the New Scholar Award from the Ellison Medical Foundation and the Zenith Award from the Alzheimer’s Association. She served on the Alzheimer’s Association Medical & Scientific Advisory Council from 2011 to 2018. Currently she is a member of the Tau Consortium Scientific Advisory Board and a co-Chair of the Scientific Review Committee of the BrightFocus Foundation.